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Uterine leiomyosarcoma, one of the most malignant
groups of uterine tumors, constitutes 0.1–2% of all
uterine malignancies. The pattern of tumor spread is
commonly to the liver or lung via the blood stream. The
treatment of most patients with stage I and II uterine
leiomyosarcomas should include at least total hysterec-
tomy and bilateral salpingo-oophorectomy. There is no
firm evidence that adjuvant chemotherapy or radiation
therapy is beneficial for these patients. However, recur-
rences develop in more than half of the cases of uterine
leiomyosarcoma, even when the disease is apparently
localized at the time of treatment.
The most common sites of recurrence are the abdo-
men and lungs, and less than 10% of cases showed re-
currence in the pelvic cavity. However, recurrences in the
laparotomy wound are extremely rare and, to our knowl-
edge, only one case has been previously reported [1].
It is still not known how neoplastic cells can implant and
grow in an abdominal scar without other concomitant
metastases.
We present a patient with uterine leiomyosarcoma
who developed a recurrence in her abdominal wall
incision and review the reports in the literature about
potential etiologies as well as the mechanism.
A 43-year-old woman, gravida 3, para 2, presented to
our gynecologic oncology clinic in February 2004, com-
plaining of self-palpable abdominal mass associated
with intermittent lower abdominal pain for more than
1 year. On pelvic examination, an enlarged uterus, the
size of which was similar to that at 12 weeks’ gestation,
was noted, and transvaginal sonography revealed a huge
uterine tumor of about 12 cm in diameter with increased
vascularity. A laparotomy was performed through a
Pfannenstiel incision. Findings included a huge uterine
tumor measuring 12×9.5×8 cm with central necrosis,
and there was no obvious disease involving the bilat-
eral ovaries, lymph nodes or omentum. The patient un-
derwent total abdominal hysterectomy, because an
atypical leiomyoma was disclosed from intraoperative
frozen section. The final pathologic evaluation was re-
ported to be uterine leiomyosarcoma with mitotic count
higher than 10 per 10 high-power fields. There was no
evidence of uterine serosal involvement. No adjuvant
treatment, such as chemotherapy or radiotherapy, was
arranged after the surgery.
The patient was free of disease until 2 years after the
operation, when a solitary mass was noted at the laparo-
tomy scar. On examination, she had a 4×4 cm hard
mass with restricted mobility in the right side of the
Pfannenstiel scar. Pelvic examination and serum tumor
markers were within reference ranges. Ultrasonography
of the abdomen showed one subcutaneous cystic mass
that was 4 cm in diameter near the laparotomy scar. The
abdominal computed tomography scan revealed a 4-cm,
well-enhanced mass at the right lower anterior abdom-
inal wall, and there was no evidence of intra-abdominal
or distant disease (Figure 1). Under the impression of
recurrent leiomyosarcoma, local excision of the mass
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Figure 1. Abdominal computed tomography showing a 4-cm,
well-enhanced mass (arrow) with a thick tail at the right lower
anterior abdominal wall, separating from the urinary bladder.
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through the previous Pfannenstiel incision was under-
taken (Figure 2). Perioperatively, the mass was found to
be hard, of 4 cm in size, and was located inferior to the
fascia of the right side of the previous laparotomy
wound. On microscopy, the tumor cell was high-grade
leiomyosarcoma and very similar to that of the primary
tumor. Additional immunohistochemical study also
showed positive expression for desmin and smooth mus-
cle actin, consistent with smooth muscle differentiation.
However, the surgical margin was not clear of tumor
cells. Postoperatively, after the wound healing, this pa-
tient received adjuvant radiotherapy to the whole pelvis
with total dose of 5,040 cGy in 28 fractions, five times
a week.
Unfortunately, a recurrent mass, 5.7 cm in diameter,
was noted over the right side of the pelvic cavity 4 months
after radiotherapy, while the laparotomy wound was can-
cer free. No metastasis of the abdominal lymph nodes
was detected. Subsequently, the patient sought a second
opinion at another hospital and underwent a second
laparotomy for a tumor-debulking surgery. The final
pathologic evaluation of the tumor mass was reported
to be consistent with recurrent leiomyosarcoma. Post-
operatively, she received adjuvant chemotherapy with
dacarbazine and epirubicin, and remained disease-free
for 9 months after the tumor excision.
Recurrences develop in more than half of the cases
of uterine leiomyosarcoma [1]. The most common sites
of recurrence are the pelvis, lungs and liver. In contrast,
metastasis in the abdominal wall incision line has rarely
been described [2]. To our knowledge, this is the second
reported case of recurrent leiomyosarcoma implanted
in an abdominal scar. Cancer recurrence at the site of
a surgical wound is a well-documented but relatively
rare event, especially in laparotomy scars. However, lapa-
roscopic port-site metastases in patients with malig-
nancies have been reported, including in those with
carcinoma of the pancreas, esophagus, stomach, liver
and colon, as well as gynecologic malignancies [3]. In
order to explain the development of laparoscopic port-
site metastasis, a number of etiologic factors have been
proposed, such as “pneumoperitoneum” and “the chim-
ney effect” [4,5]. Although these concepts remain con-
troversial, some researchers claimed that the surgical
technique actually resulted in increased tumor growth
and a higher incidence of port-site or abdominal wall
metastases, compared with gasless laparoscopy. Other
potential etiologies that have been discussed in the lit-
erature include local immune system, surgical technique,
and direct contamination of the trocar site with viable
tumor cells [6].
However, how the cancer cells implant themselves
in the laparotomy wound and grow in situ is still not
known. Furthermore, the presentation of a solitary recur-
rent tumor mass at a surgical incision wound without
other concomitant metastatic sites raises the question
of the route of spread. Positive peritoneal cytology is
one of the factors which contributes to recurrence and
poor prognosis [7]. However, only a few reports show
an increased risk of recurrence at the site of surgical
wound if positive cytology is proved, despite the com-
mon presence of cancer cells intraperitoneally [8]. Some
authors believed that malignant tumor cells implant in
the laparotomy wound at the time of surgery because
of tumor cell spillage during manipulation, and then
grow slowly, as a mechanism for skin incision metastases.
Therefore, the importance of a sterile operative field to
avoid cancer cell contamination has been emphasized
for a long time [9,10]. In addition, Kotwall et al [11] re-
ported an as-yet-unknown interplay between the host,
tumor and treatment factors that determines the viabil-
ity of implanted tumor cells. In uterine tumors, tumor
grade is also one of the most important factors in local,
regional and distant recurrence. High-grade tumors with
poorly differentiated cells have the greatest propensity
for implantation at the incision site, as in our patient [1].
Management methods of recurrent uterine leiomyo-
sarcoma at the site of a surgical wound have been
reported, but no strict guidelines are available in the
literature owing to the scanty number of cases reported.
Nair et al [1] presented a woman with high-grade spin-
dle cell sarcoma of the uterus, who underwent radical
surgical resection of isolated scar metastasis. Then, the
patient received postoperative adjuvant chemotherapy
followed by external radiation. No evidence of recurrent
tumor was noted during the 18 months of follow-up.
Although radical surgical excision with postoperative
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Figure 2. A 4×4 cm mass (arrow) over the right side of the
previous operation area, without entering into the pelvic cavity.
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adjuvant radiotherapy or chemotherapy are both sug-
gested, especially when the resection margins are not
clear [12], the outcomes remain uncertain. We treated
our patient with local excision followed by external beam
radiation therapy. Unfortunately, she was found as hav-
ing recurrent mass in the pelvic cavity, other than at
the laparotomy scar, 4 months after radiation. Whether
giving chemotherapy soon after surgical resection of
scar tumor would have benefited this patient still needs
further investigation.
In conclusion, laparotomy scar recurrence follow-
ing treatment for gynecologic cancer without other con-
comitant metastases is rare, and the route of spread
remains uncertain. In our case, a possible explanation is
the direct tumor seeding in a previous laparotomy scar
due to cell spillage during manipulation at the time of
surgery. To avoid cancer recurrence at the site of surgi-
cal wounds, we emphasize the importance of a sterile
operative field and irrigation of the pelvic cavity as much
as possible when malignancy is suggested.
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